Uday Dasika, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · West Reading, PANPI 1437150307
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $40,933 of the $50,463 with a category attached, or 81.1%. Atricure, Inc. accounts for 96.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $22,060 and has fallen 92.7% since, to $1,616 in 2025.
Across 95 payments — averaging $531.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$49K
- Intuitive Surgical$961
- Boston Scientific$195
- Edwards Lifesciences$115
- Abiomed$97
- Cook Medical LLC$93
- plus $139 from 4 others
What the payments were for
- Consulting fees$40,93381%
- Travel & lodging$7,12914%
- Food & beverage$2,3715%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 74 | $48,864 |
| Intuitive Surgical | 10 | $961 |
| Boston Scientific | 2 | $195 |
| Edwards Lifesciences | 2 | $115 |
| Abiomed | 1 | $97 |
| Cook Medical LLC | 1 | $93 |
| Philips North America LLC | 2 | $80 |
| W. L. Gore & Associates, Inc. | 1 | $26 |
| Merck | 1 | $19 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$50,463 in reported general payments places this provider in the 85th percentile of 314 thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 60 | $483 |
| Chlorhexidine Gluconate | 49 | $218 |
| ClopidogrelClopidogrel Bisulfate | 11 | $139 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in West Reading
- Joseph BavariaAllentown$1.7M
- Basel RamlawiWynnewood$1.1M
- Patrick RossWynnewood$956K
- Mark AndersonPhiladelphia$527K
- Scott GoldmanWynnewood$354K
- Frank BowenCamp Hill$310K
- Michael AckerPhiladelphia$271K
- Wilson SzetoPhiladelphia$252K
- Inderpal SarkariaPittsburgh$248K
- Nimesh DesaiPhiladelphia$203K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.